Global Consumer Genomics Market Size Hit USD 1.87 Billion by 2025, Growing at a CAGR of 20.1% from 2024 to 2032 | Coherent Market insights

Consumer Genomics [https://www.coherentmarketinsights.com/industry-reports/global-consumer-genomics-market] products generally fall into two main categories: at-home DNA testing kits and subscription-based genetic services. The kits enable users to collect saliva or cheek swabs at home, which are then shipped to a lab for analysis. The most popular direct-to-consumer options include ancestry tests-estimating ethnic heritage-and health predisposition tests-identifying genetic variants associated with conditions like cancer. As startups have driven down costs and improved accessibility, these tests have surged in popularity.

Get a Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-sample/6547

Global Consumer Genomics Market Key Takeaways

According to Coherent Market Insights (CMI), the global consumer genomics market size is expected to grow more than 3.6X, expanding from USD 1.87 Bn in 2025 to USD 6.74 Bn by 2032.

Global demand for consumer genomics products and services is projected to increase at a CAGR of 20.1% during the assessment period.

Consumables segment is set to dominate the industry, accounting for nearly two-fifths of the global consumer genomics market share in 2025.

North America remains the leading market for consumer genomics, accounting for over one-third of the global market share in 2025.

As per CMI's new global consumer genomics market analysis, Europe is set to remain the second-largest market, accounting for over one-fourth of the global share in 2025.

Asia Pacific consumer genomics market is poised to experience fastest growth during the assessment period.

Growing Demand for Personalized Healthcare Fueling Market Growth

Coherent Market Insights' latest global consumer genomics market research report offers insights into major factors driving industry growth. One such prominent growth driver is the increasing demand for personalized healthcare globally.

Modern consumers are increasingly showing interest in tailored health and wellness solutions. This is expected to drive demand for consumer genomics as it provides the necessary genetic information for personalized plans.

Genomic data helps individuals understand their genetic predispositions to manage diseases and optimize wellness strategies. Thus, growing preference for personalized healthcare will directly influence global consumer genomics market growth during the assessment period.

Request Customization : https://www.coherentmarketinsights.com/insight/request-customization/6547

Data Security and Reliability Concerns Restraining Market Growth

The global consumer genomics market outlook indicates strong future growth. However, growing concerns regarding data security as well as reliability of test results pose a barrier to widespread market expansion.

Storage and use of consumers' genetic data by third parties have raised alarms about potential data breaches and cyberattacks. These risks fuel consumer mistrust, potentially dampening the overall global consumer genomics market demand.

Moreover, variations in results from different companies for the same individuals are raising concerns about test accuracy and reliability. Such issues may hinder consumer confidence and negatively impact the global consumer genomics market growth.

Growing Demand for Ancestry Testing Opening New Growth Opportunities

There is a growing demand for genealogy-based tests amid rising curiosity about ancestral roots and ethnic lineage. This is expected to create lucrative growth opportunities for consumer genomics service providers.

Companies like 23andMe and AncestryDNA are making direct-to-consumer genetic testing services mainstream. These companies are employing user-friendly platforms and data-driven insights to deepen consumer engagement and expand their global footprint.

Growing awareness, coupled with rising prevalence of chronic diseases like cancer, diabetes, and cardiovascular diseases, is expected to boost global consumer genomics market value. Health-conscious consumers are increasingly interested in understanding their genetic predispositions to make informed lifestyle and medical decisions.

Impact of AI on the Global Consumer Genomics Market

Artificial Intelligence (AI) is emerging as a powerful tool in the global consumer genomics industry. It enhances the ability to decode vast genomic datasets with greater speed, precision, and scalability.

Adoption of machine learning and deep learning in sequencing workflows allows companies to identify complex disease-associated genetic variants more effectively. Similarly, these technologies accelerate drug discovery and generate richer polygenic risk scores for conditions like cardiovascular and oncologic disorders.

Consumer genomics companies like 23andMe and GeneDx are leading from the forefront when it comes to AI adoption. For instance, in May 2025, GeneDx announced the acquisition of Fabric Genomics to integrate AI into sequencing workflows.

Get discount on Purchase report@: https://www.coherentmarketinsights.com/insight/buy-now/6547

Emerging Global Consumer Genomics Market Trends

Increasing accessibility and affordability of DNA testing is throwing a new light into the global consumer genomics industry. Advances in genomic sequencing technologies have significantly lowered the cost of DNA analysis, making at-home DNA test kits more affordable and accessible to a broader population.

Expanding applications of consumer genomics beyond health is expected to further boost sales growth. Today, consumer genomics is being explored for applications like genetic matchmaking, pet DNA testing, and trait-based analysis for personalized nutrition, skincare, and fitness.

Advancements in genomic technologies are expected to boost growth of the consumer genomics market. Innovations like next-generation sequencing (NGS), enhanced bioinformatics tools, and AI-powered analytics have significantly improved the accuracy and interpretation of genetic test results.

Analyst's View

" The global consumer genomics industry is set for rapid expansion, owing to rising demand for personalized healthcare solutions, increasing popularity of ancestry testing, and advancements in genomic technologies," said senior analyst Nikhilesh Ravindra Patel.

Current Events and Their Impact on Global Consumer Genomics Market

Event

Description and Impact

23andMe's Expansion into Preventive Health Packages

* Description: 23andMe launched bundled preventive care packages including genetic risk screening + physician consultations in partnership with telehealth firms.

* Impact: This signals a shift from recreational DNA testing to clinical-grade value offerings.

AI-Driven Polygenic Risk Scores & Digital Integration

* Description: Starting in 2025, Bupa began offering an AI-derived polygenic risk score test ("Health Insights") to its customers, integrated into health assessments for ages 40-45+, developed by the Oxford spinout Genomics.

* Impact: This marks one of the first large-scale integrations of genomic risk screening into routine preventive care via insurers, validating DTC tests in mainstream health systems.

Mergers & Acquisitions

* Description: In April 2025, GeneDx agreed to acquire Fabric Genomics for up to $51million to boost AI-powered variant interpretation, accelerating genomic diagnostics in critical care settings like NICUs.

* Impact: Demonstrates industry consolidation to enhance interpretive speed and scalability of genomic services.

Competitor Insights

Key companies listed in global consumer genomics market report:

- Ancestry

- Mapmygenome

- 23andMe, Inc.

- Gene By Gene, Ltd.

- Color Genomics, Inc.

- Mapmygenome

- Myriad Genetics, Inc.

- Futura Genetics

- Positive Biosciences, Ltd

- Helix OpCo LLC

- Pathway Genomics

- Illumina, Inc.

- MyHeritage Ltd.

- Veritas

- Amgen, Inc.

- Diagnomics, Inc.

- Xcode Life

- Toolbox Genomics

- inui Health

- SomaLogic, Inc.

- Biomeb

- AgeCurve

- Genetic Technologies Limited

- Metabolomic Discoveries GmbH

- QuickCheck Health

Key Developments

In February 2025, Ultima Genomics partnered with multiple premium genomic service providers to offer highquality, lowcost DNA sequencing on its UG100 platform. This initiative is a part of the company's broader strategy to deliver cost-effective sequencing at an unprecedented scale.

In September 2024, Illumina announced plans to expand its presence in India and increase access to genomics to help tackle public health challenges like TB, AIDS, malaria, and other infectious diseases.

Segments covered:Global Consumer Genomics Market Segmentation, By Product and Services:

Consumables Systems Software

Global Consumer Genomics Market Segmentation, By Application:

Diagnostics

Wellness and Nutrition

Personalized Medicine

Ancestry

Others

Global Consumer Genomics Market Segmentation, By Region:

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

About Us: Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviors, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.

Media Contact
Company Name: Coherent Market Insights
Contact Person: Mr. Shah
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-consumer-genomics-market-size-hit-usd-187-billion-by-2025-growing-at-a-cagr-of-201-from-2024-to-2032-coherent-market-insights]
Phone: + 12524771362
Address:533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States
Country: United States
Website: https://www.coherentmarketinsights.com/industry-reports/global-consumer-genomics-market

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.